- Home
- IPEX vs XGN Comparison
IPEX vs XGN Comparison
Compare IPEX & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.16
HOLD
Current Price
$8.72
Company Overview
Basic Information| Metric | IPEX | XGN |
|---|---|---|
| Founded | 2024 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.0M | 110.7M |
| IPO Year | 2024 | 2014 |
Fundamental Metrics
Financial Performance| Metric | IPEX | XGN |
|---|---|---|
| Price | $3.16 | $8.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $8.86 |
| AVG Volume (30 Days) | 44.3K | ★ 239.2K |
| Earning Date | 04-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.12 |
| Revenue Next Year | N/A | $13.00 |
| P/E Ratio | $41.16 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.00 | $2.59 |
| 52 Week High | $13.02 | $12.23 |
Technical Indicators
Market Signals| Indicator | IPEX | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 21.82 | 71.93 |
| Support Level | N/A | $4.08 |
| Resistance Level | $10.70 | N/A |
| Average True Range (ATR) | 2.02 | 0.40 |
| MACD | -0.44 | 0.07 |
| Stochastic Oscillator | 5.90 | 93.20 |
Price Performance
Historical Comparison IPEX
XGN
About IPEX Inflection Point Acquisition Corp. V Class A Ordinary Shares
Inflection Point Acquisition Corp V is a blank check company.
About XGN Exagen Inc.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.